NASHVILLE, Tenn. & TAIPEI, Taiwan–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals (“Formosa”, 6838.TW), today announced a licensing agreement, whereby …
Category: News
Virginia G. Piper Charitable Trust Names Laura Smith as Director of Eyes On Learning
PHOENIX–(BUSINESS WIRE)– #Arizona–Virginia G. Piper Charitable Trust has appointed Laura Smith as the new director of Eyes On Learning, a coalition of state, local, and national organizations dedicated to improving the vision health of Arizona’s chi…
Virginia G. Piper Charitable Trust Names Laura Smith as Director of Eyes On Learning
PHOENIX–(BUSINESS WIRE)– #Arizona–Virginia G. Piper Charitable Trust has appointed Laura Smith as the new director of Eyes On Learning, a coalition of state, local, and national organizations dedicated to improving the vision health of Arizona’s chi…
Samenvatting: Biocytogen en Nanjing Chia Tai Tianqing kondigen IND-goedkeuring aan in China voor het gezamenlijk ontwikkelde anti-IGF-1R antilichaam NTB003 (BCG009)
BEIJING & NANJING, China–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) en Nanjing Chia Tai Tianqing Pharmaceutical Co. Ltd. (“NJCTTQ”) hebben bekendgemaakt dat voor hun gezamenlijk ontwikkelde injecteerbar…
Biocytogen et Nanjing Chia Tai Tianqing annoncent l’autorisation IND en Chine pour l’anticorps anti-IGF-1R NTB003 (BCG009) développé conjointement
PÉKIN et NANJING, Chine–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Pékin) Co., Ltd. (« Biocytogen », HKEX : 02315) et Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (« NJCTTQ ») ont annoncé que le NTB003 (anciennement BCG009), un candidat médica…
Resumen: Biocytogen y Nanjing Chia Tai Tianqing anuncian aprobación IND en China para el anticuerpo NTB003 (BCG009) desarrollado conjuntamente contra el IGF-1R
BEIJING y NANJING, China–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Pekín) Co. Ltd. (“Biocytogen”, HKEX: 02315) y Nanjing Chia Tai Tianqing Pharmaceutical Co. Ltd. (“NJCTTQ”) anunciaron que NTB003 (ex BCG009), un candidato a fármaco inyectable desar…
Riassunto: Biocytogen e Nanjing Chia Tai Tianqing annunciano l'approvazione IND in Cina per l'anticorpo anti-IGF-1R NTB003 (BCG009) sviluppato congiuntamente
BEIJING e NANJING, Cina–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) e Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (“NJCTTQ”) hanno annunciato che NTB003 (formerly BCG009), un farmaco candidato ini…
Biocytogen und Nanjing Chia Tai Tianqing geben IND-Zulassung in China für gemeinsam entwickelten Anti-IGF-1R-Antikörper NTB003 (BCG009) bekannt
BEIJING und NANJING, China–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. („Biocytogen“, HKEX: 02315) und Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. („NJCTTQ“) melden, dass NTB003 (zuvor BCG009), ein gemeinsam entwickelter, in…
GLP-1 RAs Linked to Doubled Risk for Macular Degeneration
Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for neovascular age-related macular degeneration in a large Canadian study. Medscape Medical News
Long-Term Exposure to Air Pollution Can Double Glaucoma Risk
Long-term exposure to air pollution increases the risk for primary open-angle glaucoma by up to 108%, a nationwide cohort study of over half a million individuals in Taiwan shows. Medscape Medical News
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Eye Health America Expands in Northeast Florida with the Addition of Schneider Eye & Wellness Center in Jacksonville Beach
JACKSONVILLE BEACH, Fla.–(BUSINESS WIRE)– #EyeCare–Eye Health America (EHA), a leading integrated eye care platform in the Southeastern United States, is proud to announce its newest partnership with Schneider Eye & Wellness Center, a respected …
Tenpoint Therapeutics Ltd. Announces FDA Acceptance of New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia
LONDON & SEATTLE–(BUSINESS WIRE)– #BRIMOCHOL–Tenpoint Therapeutics Ltd. announces FDA acceptance of New Drug Application for BRIMOCHOL™ PF for the treatment of presbyopia
Inexpensive HIV Med Improves Vision in Diabetic Eye Disease
An initial trial suggests lamivudine, an inexpensive oral drug for treating HIV, can improve vision in patients with diabetic macular edema more effectively and affordably than current therapies. Medscape Medical News
Warby Parker Announces Participation in the Baird Global Consumer, Technology & Services Conference
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that the Company will be presenting at the Baird Global Consumer, Technology & Services Confe…
Irritant Contact Dermatitis
The patient’s medical history was significant for mild atopic dermatitis, well-controlled with triamcinolone ointment used intermittently, and a background of ichthyosis vulgaris. Medscape Dermatology
A Teen With a Progressive Rash on Her Face and Hands
The patient’s medical history was significant for mild atopic dermatitis, well-controlled with triamcinolone ointment used intermittently, and a background of ichthyosis vulgaris. Medscape Dermatology
Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that To…
Study Underscores Need for Eye Exam in Psych Disorders
An analysis of a large national database shows a diagnosis of bipolar disorder or major depressive disorder is linked to an increased risk for retinal diseases in middle-aged and older individuals. Medscape Medical News
US FDA Approves Alcon’s New Dry-eye Drug (May 28)
(This May 28 story has been corrected to say ‘eye drop,’ not ‘liquid medication,’ in paragraph 3 and to remove the picture) Reuters Health Information